Neocodion® misuse:: Evolution between 1992 and 2002

被引:13
作者
Armand, C
Thirion, X
Saillard, C
Lapeyre-Mestre, M
Lambert, H
机构
[1] Hop Cent, CEIP Nancy, F-54035 Nancy, France
[2] Fac Med Marseille, Lab Sante Publ, PACA Corse Ctr Associe, Ctr Evaluat & Informat Pharmacodependance Marseil, F-13385 Marseille, France
[3] Fac Med Toulouse, Ctr Evaluat & Informat Pharmacodependance Toulous, Toulouse, France
来源
THERAPIE | 2004年 / 59卷 / 05期
关键词
Neocodion((R)); drug users; drug abuse; pharmacies network; epidemiological survey;
D O I
10.2515/therapie:2004093
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Neocodion(R), a codeine antitussive preparation (codeine camphosulfonate + Grindelia + sulfogaiacol) is known to be misused by opiate addicts. This study aimed to examine the evolution in Neocodion(R) use between 1992 and 2002. Since 1992, three surveys (1992, 1997 and 2002) investigating Neocodion(R) misuse were performed via several Community networks of pharmacists. During the same time, data on Neocodion(R) use were extracted from the French drug-dependence monitoring programme (OPPIDUM [Observation des Produits Psychotropes Illicites on Detournes de leur Utilisation Medicamenteuse]). A marked and continuous decrease in Neocodion(R)consumption was observed. The number of requests for Neocodion(R)per pharmacy and per week largely decreased from 9.9 to 2.1 between 1992 and 2002. OPPIDUM data also showed a reduction in the rate of Neocodion(R) consumption (from 8% in 1992 to 0.4% in 2002). Patients were older (30.4 years in 1992 and 33.7 years in 2002) and their socioeconomic conditions were better. Eighty-six percent of the subjects studied were poly-drug consumers. In fact, Neocodion(R) was less sought after for opiate maintenance than for its psychoactive effects. Despite the reduction in the consumption of Neocodion(R), the changes observed in the consumption patterns for this medication suggest that vigilance is still required.
引用
收藏
页码:547 / 553
页数:7
相关论文
共 17 条
[1]  
Baumevieille M, 2001, THERAPIE, V56, P15
[2]  
Bonnet N, 2001, Ann Med Interne (Paris), V152 Suppl 7, P15
[3]  
Bouley M, 2000, THERAPIE, V55, P295
[4]  
LAPEYREMESTRE M, 2000, COURRIER ADDICTIONS, V1, P27
[5]   Forged medical prescriptions in a community pharmacy network in Midi-Pyrenees area: assessment of a falsification ratio [J].
Llau, ME ;
Lapeyre-Mestre, M ;
Plas, L ;
Damase-Michel, C ;
Montastruc, JL .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 57 (12) :911-912
[6]  
MOHAMMADI R, 1999, COURRIER ADDICTIONS, V3, P108
[7]  
*OFDT, 2002, US DROG 18 PRINC RES
[8]  
*OFDT, 2001, PHEN EM DROG 2000 TE
[9]  
*OFDT, 2003, PHEN EM DROG 2002 TE
[10]  
*OFDT, 2002, PHEN EM DROG 2001 TE